The establishment of the Society was initiated in August 2011 (http://virtualbiosecuritycenter.org/blog/op-ed-enhancing-biosecurity-and-biosafety-in-bangladesh) as a professional society to foster best and sustainable Biosafety and Biosecurity practices in Bangladesh considering the current situation of infectious diseases outbreaks and increasing demands for research and diagnostics of these disease-causing agents. Virtual Biosecurity Center (VBC) and Biosafety Biosecurity International (BBI) supported the initiation of the activity regarding the formation of the Society. icddr,b played the key role organizing and hosting all those activities. Enhancing Biosafety and Biosecurity by inculcating local scientists in the ethical considerations of conducting life-sciences research and the development of codes of conducts for  such research; promoting local leadership for a sustained Biosafety Biosecurity presence; and laying the foundation to create a Biosafety and Biosecurity Society, which can promote codes, support local learning initiatives, and as a professional society can play a role in promulgating national Biosafety and Biosecurity legislation is a holistic approach.

We thank Centers for Disease Control and Prevention (CDC), Atlanta, USA and Biosecurity Engagement Program (BEP) of the United States Department of State for substantial support for the development of this website.

Upcoming Program

Preconference Workshop and Annual Contference 2021 on:

Biosafety and Biosecurity in Biotechnology: COVID-19 and Beyond

Registration is open from 5 November to 3 January 2022.

Preconference Workshop:

Day 1: 19 January 2022

• WS1: Principles and Practices of Biosafety and Biosecurity in Human Health Laboratories
• WS2: Biosafety and Biosecurity in Animal Health Laboratories
• WS3: Biological Safety Cabinet Selection, Installation and Certification

Day 2: 20 January 2022

• WS4: Biosafety and Biosecurity Practices in Clinical Care
• WS 5: Biohazardous Waste Management

Annual Conference:

Day 1: 21 January 2022

• 15:00 – 16:00     Inaugural Ceremony
• 16:00 – 17:00     Technical Session 1

Biosafety and Biosecurity in Laboratory Diagnosis and Research

• 17:00 – 18:00     Technical Session 2

Biosafety and Biosecurity in Clinical Care                                                                

Day 2: 22 January 2022

• 09:30 – 11:30     Technical Session 3

Biosecurity in Agriculture, Animal and Veterinary Sciences

• 11:30 – 12:30     Technical Session 4

Antimicrobial Resistance as the World Long Lasting Pandemic Threat: Biosafety and Biosecurity Perspective

• 12:30 – 14:00     Lunch and Prayer Break
• 14:00 – 15:00     Technical Session 5

Biosafety and Biosecurity in COVID-19 Care and Management

• 15:00 – 16:00     Technical Session 6

Past, Present and Future of Biohazardous Waste Management

• 16:00 – 16:30     Closing Ceremony

Submit Abstract and

Register for the program!

========================================================================================

About SARS-CoV

CoVs are a large family of viruses that cause illness ranging from the common cold caused by four human HCoVs that are endemic globally are HCoV-229E, HCoV-NL63, HCoV-HKU1 as well as HCoV-OC43, and more severe diseases caused by Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). The novel coronavirus (nCoV) is a new strain that has not been previously identified in humans. CoVs are transmitted between animals and humans. Several known CoVs are circulating in animals that have not yet infected humans. 

Respiratory symptoms, fever, cough, shortness of breath, and breathing difficulties are the common signs of infection. Infection can cause pneumonia, severe acute respiratory syndrome, kidney failure, and even death, in more severe cases.

To prevent infection spread, regular hand washing, covering mouth and nose when coughing and sneezing, thoroughly cooking meat and eggs are the standard recommendations. Close contact with anyone showing symptoms of respiratory illness such as coughing and sneezing must be restricted.

========================================================================================

Weblinks/Updates/Guidelines

To know the detail about MERS and SARS CoV follow the link MERS and SERS CoV. The information presented here are, collected from pathogens safety data sheet Canada, presented without any change! WHO has published its interim guidance for laboratory biosafety related to 2019-nCoV/COVID-19/SARS-CoV-2 that are available at Bangladesh Biosafety and Biosecurity Society (bdbiosafetysecurity.org).

To know the detail about Infection prevention and control during health care when SARS-CoV2 is suspected please visit: Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected, Interim guidance & Interim Clinical Guidance for Management of Patients with Confirmed 2019 Novel Coronavirus (2019-nCoV) Infection

========================================================================================

Laboratory testing for SARS-CoV

The etiologic agent responsible for the cluster of pneumonia cases in Wuhan has been identified as a novel beta coronavirus, (in the same family as SARS-CoV and MERS-CoV) via next-generation sequencing (NGS) from cultured virus or directly from samples received from several pneumonia patients.

Electron microscopy revealed a virus with a characteristic crown morphology: a coronavirus. Working directly from sequence information, the team developed a series of genetic amplification (PCR) assays used by laboratories associated with the China CDC to detect several dozen cases as of today.

China CDC Primers and probes for detection 2019-nCoV (24 January 2020)

Diagnostic detection of Wuhan coronavirus 2019 by real-time RT-PCR – Charité, Berlin Germany (17 January 2020)

Detection of 2019 novel coronavirus (2019-nCoV) in suspected human cases by RT-PCR – Hong Kong University (23 January 2020)

PCR and sequencing protocol for 2019-nCoV - Department of Medical Sciences, Ministry of Public Health, Thailand (Updated 28 January 2020)

PCR and sequencing protocols for 2019-nCoV- National Institute of Infectious Diseases Japan (24 January 2020)

US CDC panel primer and probes– U.S. CDC, USAV – U.S. CDC, USA (28 January 2020)

• US CDC panel primer and probes– U.S. CDC, USA (28 January 2020)

News Letters 

This quarterly Newsletter is dedicated to strengthening Biosafety and Biosecurity status in Bangladesh leading to sustainable development in Health and Agriculture. Contact the "Managing Editor" for communicating information on biosafety and biosecurity and related advancement and issues to publish on this page.

করোনার ভাইরাস ছড়িয়ে পড়া এবং এই ভাইরাসের সংক্রমণ নিয়ন্ত্রণ করতে সাধারণ সচেতনতা আর আমাদের যা করতে হবে

========================================================================================

Special Activity

Biohazard Bags, Sharps Containers and PPE are available!

Place your requirement to biohazardmanagebd@gmail.com